Home Your basket
• The input of autogenous g...
   Price 10.50 €
• Evaluation and treatment ...
   Price 8.50 €
• Determination of oesophag...
   Price 10.50 €
• Management of peritonsill...
   Price 5.50 €
• Interest of MIBI scintigr...
   Price 10.50 €
• Dysphonia in children: Re...
   Price 12.50 €
• Plastic surgery indicatio...
   Price 10.50 €
• Thyroid surgery (356 case...
   Price 10.50 €
• Myasthenia gravis and oro...
   Price 5.50 €
• Electrorhinomanometric ev...
   Price 10.50 €
• Surgical procedure in fir...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• The “Deglutition Handicap...
   Price 10.50 €
• Papillary thyroid carcino...
   Price 10.50 €
• Migrant foreign body of t...
   Price 10.50 €
• Liposarcoma of the hypoph...
   Price 5.50 €
• Subdural empyema complica...
   Price 5.50 €
• Surgical management of pa...
   Price 10.50 €
• Desmoplastic ameloblastom...
   Price 5.50 €
• Cemento-ossifying fibroma...
   Price 8.50 €
• Combined induction chemot...
   Price 10.50 €
• Vertigo and pathology of ...
   Price 10.50 €
• Dynamic palatography: Dia...
   Price 12.50 €
• Respiratory epithelial ad...
   Price 12.50 €
• Malt lymphoma of the orbi...
   Price 10.50 €
• Osteoid osteomas in the f...
   Price 5.50 €
• Role and importance of pH...
   Price 12.00 €
• Usefulness and limitation...
   Price 10.50 €
• Defects in accuracy of th...
   Price 10.50 €
• Unusual location of pleom...
   Price 12.50 €
• Efficacy and safety of mo...
   Price 10.50 €
• Acute infectious complica...
   Price 8.50 €
• Effect of vestibular neur...
   Price 10.50 €

Total Order 316.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2008 o

ONCOLOGY

Interest of the chest CT scanning in head and neck cancer


Authors : Dequanter D, Lothaire P, Lemort M, Canizares Perez A. C, Lalami Y, Awada AH. (Montigny le Tilleul)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,4:273-276.

Article published in french
Downloadable PDF document french



Summary : Introduction: The overall survival rate for patients with head and neck squamous cell carcinoma remains disappointingly static despite improved locoregional control. This has been attributed to the development of distant metastases and second primary malignancies in these patients, a large proportion of which occur in the thorax. The goal of this study is to determine the incidence of newly thoracic malignancies diagnosed initially and during the follow-up in head and neck patients by chest computed tomography. Methods: We retrospectively analysed the incidence of thoracic malignancies in 77 patients presented newly diagnosed cancer of the head and neck. Results: 15/77 patients were found to have thoracic malignancies. In 10/77 patients (14%) the diagnosis was made at the same time that the initial head and neck cancer. In 5/77 patients, the thoracic malignancies were diagnosed during the follow-up. In 3 of the 5 cases, the pulmonary lesion was diagnosed in patients with local recurrent tumours. The primary site or the stage had an effect on the incidence of simultaneous thoracic malignancies. Conclusion: The presence of distant metastases and second primary malignancies has major implications in the management and prognosis of patients presenting with head and neck carcinoma. We recommend a CT scanning of the thorax in the staging of patients presenting with head and neck cancer but also in the follow-up, particularly in patients with an advanced pharyngolaryngeal cancer.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE